Diluted Russell Viper Venom Time (dRVVT) has become the most popular test to detect Lupus Anticoagulant (LA). dRVVT is more sensitive than other global tests employed to detect LA and is not affected by inhibitors of factor VIII or IXc

This is a special blood test to find out if your body is making certain antibodies or proteins that cause you to have a blood-clotting disorder.

screen ratio (<1.20): A normal DRVVT screen ratio (<1.20) indicates that lupus anticoagulant (LA) is not present or not detectable

The Lupus Anticoagulant (LA) test and the Dilute Russell's Viper Venom Time (dRVVT) test are two commonly used tests to diagnose lupus anticoagulant, which is an autoimmune disorder associated with an increased risk of blood clotting. Here's how to interpret the results of these tests: Lupus Anticoagulant (LA) Test: The LA test detects the presence of antibodies that interfere with normal blood clotting, leading to a prolonged clotting time in vitro. Interpretation: Positive Result: A positive LA test indicates the presence of lupus anticoagulant. It suggests an increased risk of abnormal blood clotting (thrombosis) and may be associated with conditions such as antiphospholipid syndrome (APS), systemic lupus erythematosus (SLE), or other autoimmune disorders. Negative Result: A negative LA test does not rule out the possibility of APS or other clotting disorders. False-negative results can occur, particularly if the test is performed during periods of low antibody activity or if the patient is receiving anticoagulant therapy. Dilute Russell's Viper Venom Time (dRVVT) Test: The dRVVT test measures the time it takes for blood to clot in the presence of diluted Russell's viper venom, which is sensitive to the presence of lupus anticoagulant. Interpretation: Prolonged Result: A prolonged dRVVT suggests the presence of lupus anticoagulant or other clotting abnormalities. It indicates resistance to clot formation, potentially increasing the risk of thrombosis. Normal Result: A normal dRVVT result is consistent with the absence of lupus anticoagulant under the conditions of the test. However, a normal result does not entirely rule out the presence of lupus anticoagulant, as false-negative results can occur. Clinical Correlation: Interpretation of LA and dRVVT test results should be done in conjunction with the patient's clinical history, symptoms, and other laboratory findings. A positive LA test or prolonged dRVVT result, particularly in the absence of anticoagulant therapy or known coagulation disorders, may warrant further evaluation for underlying autoimmune or thrombotic conditions. Additional Testing: Confirmation of lupus anticoagulant may require repeat testing, using different reagents or methods, and/or performing additional tests such as the activated partial thromboplastin time (aPTT) or mixing studies. Evaluation for associated conditions such as APS or SLE may involve further laboratory testing, imaging studies, and consultation with specialists in hematology, rheumatology, or immunology. Interpretation of LA and dRVVT test results should be performed by healthcare providers experienced in laboratory medicine, hematology, or coagulation disorders. It's essential to consider the patient's clinical context and other relevant factors when interpreting these tests and determining appropriate management strategies for patients at risk of thrombosis or autoimmune disease.

Blood